U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2023
446
Name Type Language
Rozanolixizumab
INN   WHO-DD  
USAN   INN  
Official Name English
Immunoglobulin G4, anti-(human FcRn receptor) (human-Rattus norvegicus monoclonal UCB 7665 heavy chain), disulfide with human-Rattus norvegicus monoclonal UCB 7665 light chain, dimer
Preferred Name English
Rozanolixizumab [WHO-DD]
Common Name English
UCB-7665
Code English
rozanolixizumab [INN]
Common Name English
ROZANOLIXIZUMAB [USAN]
Common Name English
ROZANOLIXIZUMAB [JAN]
Common Name English
UCB7665
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
NCI_THESAURUS C574
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
EU-Orphan Drug EU/3/18/2131
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
FDA ORPHAN DRUG 669918
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
FDA ORPHAN DRUG 636618
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
Code System Code Type Description
USAN
LM-43
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
SMS_ID
100000173495
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
INN
10213
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
FDA UNII
P7186074QC
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
CAS
1584645-37-3
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
DRUG BANK
DB14919
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
DAILYMED
P7186074QC
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
NCI_THESAURUS
C152270
Created by admin on Tue Apr 01 18:02:26 GMT 2025 , Edited by admin on Tue Apr 01 18:02:26 GMT 2025
PRIMARY
ACTIVE MOIETY
Rozanolixizumab
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966